Dr. Genevieve Boland, Harvard Medical School

Multi-modality approach to predicting and monitoring immunotherapy response and resistance

Overcoming T- cell homing challenges in CAR-T cell cancer therapies
Prof. Ann Ager, Professor of Cellular Immunity and Immunotherapy, Cardiff University
12:00 (BST) / 13:00 (CEST) / 07:00 (EDT) / 04:00 (PDT)
Add to Calendar

NMR-based metabolomics in breast cancer research
Dr. Tone Frost Bathen, Head Professor, MR Cancer Group
12:45 (BST) / 13:45 (CEST) / 07:45 (EDT) / 04:45 (PDT)
Add to Calendar

Plasma proteomics predicts response to immunotherapy and provides biological insights into tumor-immune system interactions
Dr. Marijana Rucevic, Scientific Director, Immuno-Oncology, Olink Proteomics
13:30 (BST) / 14:30 (CEST) / 08:30 (EDT) / 05:30 (PDT)
Add to Calendar

TCR targets validation through T cell activation
Dr. Anna Pasetto, Assistant Professor & Managing Director of pre-GMP facility, Karolinska Institute
14:15 (BST) / 15:15 (CEST) / 09:15 (EDT) / 06:15 (PDT)
Add to Calendar

Multi-modality approach to predicting and monitoring immunotherapy response and resistance
Dr. Genevieve Boland, Assistant Professor, Harvard Medical School
15:00 (BST) / 16:00 (CEST) / 10:00 (EDT) / 07:00 (PDT)
Add to Calendar

Scientists' Choice Awards: Join us to celebrate the best new life sciences technologies of the year
SelectScience
15:45 (BST) / 16:45 (CEST) / 10:45 (EDT) / 07:45 (PDT)
Add to Calendar

New advances in high-throughput drug screening using TrueGel3D^® HTS Hydrogel 3D Cell Culture Plates
Nick Asbrock, Product Manager, Stem and 3D Cell Culture, MilliporeSigma
16:30 (BST) / 17:30 (CEST) / 11:30 (EDT) / 08:30 (PDT)
Add to Calendar

Challenge and improve your DNA / RNA sample preparation: An introduction to bead-beating technology
Dr. François d’Hubert, Product Manager, and Dr. Floriane Cohen, Application Scientist, Bertin Instruments 
17:15 (BST) / 18:15 (CEST) / 12:15 (EDT) / 09:15 (PDT)
Add to Calendar

Targeting metabolism to treat pancreatic cancer 
Dr. Chris Halbrook, Assistant Professor, University of California, Irvine
18:00 (BST) / 19:00 (CEST) / 13:00 (EDT) / 10:00 (PDT)
Add to Calendar

Optimizing immunohistochemistry and multiplex immunofluorescence success with antibody validation
Dr. Mike Spencer, Director of Immunohistochemistry and Digital Pathology, Fortis Life Sciences
18:45 (BST) / 19:45 (CEST) / 13:45 (EDT) / 10:45 (PDT)
Add to Calendar

The impact of COVID-19 on pediatric medulloblastoma: A global response
Dr. Noelle Cutter, Associate Professor, New York’s Molloy College
19:30 (BST) / 20:30 (CEST) / 14:30 (EDT) / 11:30 (PDT)
Add to Calendar

Profiling of the immune system of multiple myeloma patients at diagnosis and after treatment using mass cytometry by time-of-flight (CyTOF)
Dr. Komal Kumar Javarappa, Postdoctoral Researcher, University of Helsinki
12:00 (BST) / 13:00 (CEST) / 07:00 (EDT) / 04:00 (PDT)
Add to Calendar

Proteomic analysis to predict response to immunotherapy 
Dr. Ofer Sharon, CEO, OncoHost
12:45 (BST) / 13:45 (CEST) / 07:45 (EDT) / 04:45 (PDT)
Add to Calendar

Interrogating complex tumors by multiomic spatial profiling
Dr. Anushka Dikshit, Application Scientist, Bio-Techne
13:30 (BST) / 14:30 (CEST) / 08:30 (EDT) / 05:30 (PDT)
Add to Calendar

One workflow, endless options: NGS workflow solutions
Brigette Brown-Kipphut, Field Application Scientist, Agilent Technologies
14:15 (BST) / 15:15 (CEST) / 09:15 (EDT) / 06:15 (PDT)
Add to Calendar

Cell-based assays to functionally characterize immunotherapy
Dr. Chris Langdsorf, R&D Staff Scientist, Thermo Fisher Scientific 
15:00 (BST) / 16:00 (CEST) / 10:00 (EDT) / 07:00 (PDT)
Add to Calendar

Identifying and targeting chromosome instability genes in cancer 
Dr. Kirk McManus, Associate Professor, University of Manitoba
15:45 (BST) / 16:45 (CEST) / 10:45 (EDT) / 07:45 (PDT)
Add to Calendar

Get the most from your samples: Higher yields of higher-quality RNA and DNA using the Ionic^® Purification System
Lewis Marshall, Director of Microfluidics, Purigen Biosystems
16:30 (BST) / 17:30 (CEST) / 11:30 (EDT) / 08:30 (PDT)
Add to Calendar

Predict anticancer efficacy with a new in vitro 3D modeling platform
Dr. Kolin Hribar, Founder and CEO, Cypre, and Dr. Julia Schueler, Research Director, Charles River Laboratories
17:15 (BST) / 18:15 (CEST) / 12:15 (EDT) / 09:15 (PDT)
Add to Calendar

Targeting tumor mutations with personalized T cell therapy of cancer
Dr. Gavin Bendle, Vice President of R&D at Neogene Therapeutics
18:00 (BST) / 19:00 (CEST) / 13:00 (EDT) / 10:00 (PDT)
Add to Calendar

Evaluating the heterogeneity of B cells and TLS in lung cancer patients for improved immunotherapeutics
Dr. Tullia C. Bruno, Assistant Professor, University of Pittsburgh
18:45 (BST) / 19:45 (CEST) / 13:45 (EDT) / 10:45 (PDT)
Add to Calendar

PD-1 mechanism of action: What do we know?
Prof. Adil Daud, Clinical Professor, University of California
19:30 (BST) / 20:30 (CEST) / 14:30 (EDT) / 11:30 (PDT)
Add to Calendar

Pharmacokinetic services: Tools for cancer research
Samer Sansil, Core Staff Scientist, Moffitt Cancer Center
19:30 (BST) / 20:30 (CEST) / 14:30 (EDT) / 11:30 (PDT)
Add to Calendar